Back to News
Market Impact: 0.05
Compugen to Participate in a Fireside Chat at the H.C. Wainwright 3rd Annual AI Based Drug Discovery & Development Conference
Source: PR Newswire
Healthcare & Biotech
Clinical-stage cancer immunotherapy company Compugen announced that its management will participate in a fireside chat at the H.C. Wainwright 3rd... The announcement provides no financial results, guidance, or other material business update.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Why is Telix Pharmaceuticals stock rallying today?
- Why is Natera stock sliding today?
- Xenon Pharmaceuticals stock hits 52-week low at 36.06 USD
- ArriVent BioPharma Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into ArriVent BioPharma (AVBP)
- McKesson and CD&R agree to acquire Option Care Health for $5.8 billion
- LQDA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Liquidia Corporation